Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
JIMD Reports|October 8, 2013
Novel association of early onset hepatocellular carcinoma with transaldolase deficiencyCharles A Leduc, Elizabeth E Crouch, Ashley Wilson, et al.Annals of Cardiothoracic Surgery|October 25, 2017
Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyondAdam Chakos, Ashley Wilson-Smith, Sameer Arora, et al.Ohio Journal of Public Health|May 1, 2026
Engaging Communities to Address the Opioid Crisis in Ohio: Lessons LearnedAmy Farmer, Brittany Joseph, Kendra Green, et al.Cold Spring Harbor Molecular Case Studies|June 7, 2019
Clinical and genetic characterization of individuals with predicted deleterious PHIP variantsKirsten E Craddock, Volkan Okur, Ashley Wilson, et al.Clinics and Research in Hepatology and Gastroenterology|January 20, 2023
Development and validation of a multivariable risk factor questionnaire to detect oesophageal cancer in 2-week wait patientsKai Man Alexander Ho, Avi Rosenfeld, Áine Hogan, et al.American Journal of Medical Genetics. Part A|November 27, 2018
Gain-of-function variants in the ODC1 gene cause a syndromic neurodevelopmental disorder associated with macrocephaly, alopecia, dysmorphic features, and neuroimaging abnormalitiesLance H Rodan, Kwame Anyane-Yeboa, Karen Chong, et al.Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.Proceedings of the National Academy of Sciences of the United States of America|July 28, 2025
Rare variants in BMAL1 are associated with a neurodevelopmental syndromeVishnu Anand Cuddapah, Dechun Chen, Bumsik Cho, et al.Fetal Diagnosis and Therapy|May 23, 2015
New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome)Lea Tuzovic, Sha Tang, Russell S Miller, et al.BMC Cancer|August 5, 2018
Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid refluxJudith Offman, Beth Muldrew, Maria O'Donovan, et al.Pageof 6